Remdesivir for COVID-19 treatment Remdesivir is a broad-spectrum anti-viral nucleotide analog drug. Remdesivir is the only drug approved by Food and Drug Administration (FDA) for COVID-19 treatment. Those hospitalized patients who require minimal supplemental oxygen are recommended Remdesivir. As far as, hospitalized patients who require mechanical ventilation are concerned there is insufficient data for the recommendation of Remdesivir. The criteria for use of Remdesivir • Children – 12 years or older • Adults – 40 kg or more • Pregnant women – safe to use